Table 3 Postoperative characteristics of the study population.
From: Utility of heparin-binding protein following cardiothoracic surgery using cardiopulmonary bypass
Variable | All (n = 1475) | HBP > 41 (n = 489) | HBP ≤ 41 (n = 986) | p | Missing |
|---|---|---|---|---|---|
Peak CKMB concentration (µg/L) | 18 (12–29) | 24 (15–46) | 16 (12–23) | < 0.001* | 9 |
Peak lactate concentration (mmol/L) | 2.20 (1.70–3.00) | 2.50 (2.00–3.50) | 2.10 (1.60–2.70) | < 0.001* | 7 |
Peak CRP concentration (mg/L) | 121 (57–193) | 140 (83–211) | 102 (48–183) | < 0.001* | 975 |
Peak WBC count (× 109/L) | 12.7 (10.5–15.2) | 13.7 (11.1–17.4) | 12.3 (10.3–14.6) | < 0.001* | 200 |
Peak creatinine concentration (µmol/L) | 98 (81–129) | 107 (88–169) | 94 (80–119) | < 0.001* | 7 |
Total dose (μg) norepinephrine administered per kilogram | 12.47 (2.63–48.40) | 30.43 (5.09–145.07) | 8.33 (1.94–30.65) | < 0.001* | 0 |
Duration of norepinephrine administration (h) | 15 (9–20) | 17 (12–33) | 14 (8–18) | < 0.001* | 0 |
Total dose (mg) dobutamine administered per kilogram | 0 (0–0.79) | 0 (0–2.36) | 0 (0–0.19) | < 0.001* | 0 |
Duration of dobutamine administration (h) | 0 (0–10) | 0 (0–16) | 0 (0–4) | < 0.001* | 0 |
Time on ventilator (h) | 4.33 (2.98–7.10) | 5.43 (3.43–14.04) | 4.05 (2.82–6.02) | < 0.001* | 0 |
> 48 h on ventilator | 64 (4.3) | 46 (9.4) | 18 (1.8) | < 0.001 | 0 |
Postoperative infection | 65 (4.4) | 39 (8.0) | 26 (2.6) | < 0.001 | 0 |
Postoperative stroke | 35 (2.4) | 20 (4.1) | 15 (1.5) | 0.002 | 0 |
Postoperative CRRT or dialysis | 48 (3.3) | 35 (7.2) | 13 (1.3) | < 0.001 | 0 |
Postoperative kidney injury | 103 (7.0) | 72 (14.7) | 31 (3.1) | < 0.001 | 0 |
Postoperative multiple organ failure | 19 (1.3) | 16 (3.3) | 3 (0.3) | < 0.001 | 0 |
Reoperation due to bleeding | 50 (3.4) | 21 (4.3) | 29 (2.9) | 0.176 | 0 |
Postoperative IABP | 45 (3.1) | 24 (4.9) | 21 (2.1) | 0.003 | 0 |
New-onset atrial fibrillation | 386 (26.2) | 144 (29.4) | 242 (24.5) | 0.044 | 0 |
30-day mortality | 22 (1.5) | 17 (3.5) | 5 (0.5) | < 0.001 | 0 |
